Uses exome and genome sequencing to identify rare genetic variants associated with early-onset Alzheimer's disease, frontotemporal lobar degeneration, and related neurodegenerative disorders. Integrates large-scale genetic analysis with functional studies to clarify disease mechanisms and discover novel risk genes.